Table 1.
Author | Age (y) | ASA | Type of surgery | DEX dose | MDZ dose | Route/timing of DEX | Route/timing of MDZ | Sedation/anxiety scores |
---|---|---|---|---|---|---|---|---|
Akin, 2012 | 2–9 | I | ADT | 1.0 µg/kg | 0.2 mg/kg | Intranasal 45–60 min | Intranasal 45–60 min | Modified observer’s assessment |
Arora, 2014 | 1–4 | I–II | Urogenital surgery | 4.0 µg/kg | 0.5 mg/kg | Oral 60 min | Oral 30 min | 4-point scale |
Faritus, 2015 | 2–12 | I–II | On-pump heart surgery | 2.0 µg/kg | 0.5 mg/kg | Oral 45 min | Oral 45 min | Ramsay |
Ghali, 2011 | 4–12 | I–II | ADT | 1.0 µg/kg | 0.5 mg/kg | Intranasal 60 min | Oral 30 min | MOAA/S mYPAS |
Hosokaw, 2010 | 1/12–12 | I–II | Cardiac surgery | 0.6 µg/kg per h | 0.5 mg/kg | Intranasal 30 min | Intranasal 30 min | Ramsay |
Mountain, 2011 | 1–6 | I–II | Dental surgery | 4.0 µg/kg | 0.5 mg/kg | Oral 45 min | Oral 45 min | 4-point scale |
Ozcengiz, 2011 | 3–9 | I–II | Oesophageal dilatation | 2.5 µg/kg | 0.5 mg/kg | Oral 45 min | Oral 45 min | Emergence agitation |
Pant, 2014 | 1–12 | I–II | Inguinal hernia repair, orchidopexy, circumcision | 1.5 µg/kg | 0.25 mg/kg | Intranasal >45 min | Intranasal >20 min | MOAA/S |
Savla, 2013 | 1–6 | I–II | Short elective surgery | 2.0 µg/kg | 0.5 mg/kg | Oral 30 min | Intranasal 30 min | Ramsay |
Schmidt, 2007 | 7–12 | I-II | Ambulatory surgery | 1.0 µg/kg | 0.5 mg/kg | Oral 45 min | Oral 30 min | STAIC STAI |
Sheta, 2013 | 3–6 | I–II | Dental surgery | 1.0 µg/kg | 0.5 mg/kg | Intranasal 45–60 min | Intranasal 45–60 min | 4-point scale |
Yuen, 2008 | 2–12 | I–II | Minor surgery | 0.5 or 1.0 µg/kg | 0.5 mg/kg | Oral 30 min | Oral 30 min | MOAA/S |
ASA, American Society of Anesthesiologists physical status; DEX, dexmedetomidine; MDZ, midazolam; ADT, adenotonsillectomy; MOAA/S, modified from the observer assessment of alertness and sedation scale; mYPAS, modified Yale preoperative anxiety scale; STAIC, State-Trait Anxiety Inventory for Children; STAI, State-Trait Anxiety Inventory for Adults.